MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ygyno.2026.06.015

Медицинская библиотека · Gynecologic oncology · 2026

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Montassier Thomas, Laas Enora, Hotton Judicael, Berton-Rigaud Dominique, Bonneau Claire, Fernandez Yolanda, Guyon Frédéric, Joly Florence, Gauroy Elodie, Ray-Coquard Isabelle, Perrin Morgane, Favier Laure, Vegas Hélène, Emambux Sheik, Dorri Navid Mokarram, Madad-Zadeh Sabrina, Gouy Sébastien, Lecuru Fabrice, Paoletti Xavier, Gaillard Thomas

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

INTRODUCTION

In high-grade serous ovarian carcinoma (HGSOC), time to first recurrence is a major prognostic factor guiding therapeutic management. However, this parameter remains poorly studied in low-grade serous ovarian carcinoma (LGSOC), a rare subtype characterized by indolent progression and marked chemoresistance. Moreover, AGO criteria for selecting candidates for secondary cytoreductive surgery appear poorly applicable to LGSOC, highlighting the need for specific prognostic markers.

METHODS

We conducted a multicenter retrospective study using the national LGSC database from the French Rare Malignant Gynaecologic Tumor Network. Patients with recurrent LGSOC were included. Associations between time to first recurrence, post-relapse survival (PRS), and post-relapse progression-free survival (PR-PFS) were assessed using Cox proportional hazards models adjusted for established prognostic factors. The association between time to recurrence and completeness of secondary cytoreduction was evaluated using multivariable logistic regression.

RESULTS

Among 211 patients, the median time to first recurrence was 32 months (IQR 19-63). Longer recurrence intervals were associated with improved outcomes. In multivariable analysis, patients relapsing at 24-48 months (PRS: HR 0.50; 95% CI 0.25-0.97) and ≥48 months (PRS: HR 0.25; 95% CI 0.11-0.58) had significantly better survival compared with the 12-24 month group. Similar results were observed for PR-PFS, with a significant benefit for ≥48 months (HR 0.36; 95% CI 0.19-0.70). Incorporating time to recurrence improved model discrimination. Time to recurrence was not associated with completeness of secondary cytoreduction.

CONCLUSION

Time to first recurrence is an independent prognostic factor in LGSOC. Its integration into prognostic models may improve patient stratification and refine selection for secondary cytoreductive surgery.

Для цитирования: Montassier Thomas, Laas Enora, Hotton Judicael, Berton-Rigaud Dominique, Bonneau Claire, Fernandez Yolanda, Guyon Frédéric, Joly Florence, Gauroy Elodie, Ray-Coquard Isabelle, Perrin Morgane, Favier Laure, Vegas Hélène, Emambux Sheik, Dorri Navid Mokarram, Madad-Zadeh Sabrina, Gouy Sébastien, Lecuru Fabrice, Paoletti Xavier, Gaillard Thomas. Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.. Gynecologic oncology. 2026. DOI: 10.1016/j.ygyno.2026.06.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.